In Stock Human Glp-1r Protein-nanodisc (glp-hm1n123) Bundle [STaAcMWE]

In Stock Human Glp-1r Protein-nanodisc (glp-hm1n123) Bundle [STaAcMWE]

Introducing the In Stock Human Glp-1r Protein-nanodisc (glp-hm1n123) Bundle [STaAcMWE], a cutting-edge research tool designed for scientists and researchers in the field of endocrinology and diabetes. This product is a high-purity recombinant protein, engineered to provide accurate and reliable results in your experiments. The GLP-1R Protein-Nanodisc is a revolutionary nanodisc technology that enhances the stability and functionality of the GLP-1R protein, making it an ideal choice for various applications.

• High Purity: Our GLP-1R Protein-Nanodisc is produced through a rigorous purification process, ensuring a high level of purity for reliable experimental results.
• Stable and Functional: The nanodisc technology stabilizes the GLP-1R protein, maintaining its functionality and reducing the risk of degradation during storage and use.

Product Properties and Specifications

The In Stock Human Glp-1r Protein-nanodisc (glp-hm1n123) Bundle [STaAcMWE] is a recombinant protein produced in E. coli. It is expressed as a fusion protein with a C-terminal His tag, which facilitates purification and detection. The protein is provided in a lyophilized form, making it convenient for storage and transportation. The molecular weight of the protein is approximately 42 kDa, and it is designed to mimic the natural structure and function of the human GLP-1R receptor.

• Expression System: E. coli
• Expression Tag: C-terminal His tag
• Form: Lyophilized powder

Practical Uses and Benefits

The In Stock Human Glp-1r Protein-nanodisc (glp-hm1n123) Bundle [STaAcMWE] is a versatile tool for various research applications, including cell-based assays, binding studies, and receptor activation assays. Its high purity and stability make it an excellent choice for investigating the role of GLP-1R in metabolic diseases, such as type 2 diabetes and obesity. Researchers can utilize this product to study the effects of GLP-1R agonists and antagonists, providing valuable insights into potential therapeutic targets.

• Research Applications: Cell-based assays, binding studies, receptor activation assays
• Target Disease: Metabolic diseases, such as type 2 diabetes and obesity
• Therapeutic Insights: Investigate the effects of GLP-1R agonists and antagonists